Advertisement

Topics

Emergent BioSolutions Inc. Company Profile

09:46 EST 22nd November 2017 | BioPortfolio

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent’s product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia. Additional information may be found at www.emergentbiosolutions.com.


News Articles [96 Associated News Articles listed on BioPortfolio]

Emergent BioSolutions embarks on another spending spree

Shares of US biotech firm Emergent BioSolutions closed up 3.3% at $36.04 yesterday, after it announced…

$175.41 Million in Sales Expected for Emergent Biosolutions, Inc. (EBS) This Quarter

Equities analysts predict that Emergent Biosolutions, Inc. will announce sales of $175.41 million for the current quarter, Zacks reports. Two analysts have provided estimates for Emergent Biosolutions...

Emergent Biosolutions (EBS) versus Theravance Biopharma (TBPHV) Head to Head Contrast

Theravance Biopharma and Emergent Biosolutions are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownershi...

Emergent BioSolutions strengthens manufacturing infrastructure with FDA-licensure

The US Food and Drug Administration (FDA) has approved Emergent BioSolutionsâ supplemental Biologics License Application (sBLA) for the manufacture of ACAM2000, the only FDA-licensed smallpox vaccine...

Emergent BioSolutions buying rights to smallpox vaccine

Emergent BioSolutions has entered into an agreement to acquire the ACAM2000 (Smallpox [Vaccinia] Vaccine,…

Emergent BioSolutions to buy GSK’s anthrax treatment raxibacumab

Emergent BioSolutions has agreed to acquire GlaxoSmithKline’s (GSK) anthrax monoclonal antibody, raxibacumab, for around $96m.

Emergent BioSolutions To Buy ACAM2000 Business From Sanofi For Up To $125 Mln

PARIS (dpa-AFX) - Emergent BioSolutions Inc. (EBS) Friday announced that it has entered into an agreement to acquire the ACAM2000, (Smallpox (Vaccinia) Vaccine, Live) business of Sanofi (SNYNF, SN...

Emergent Biosolutions acquires monoclonal antibody raxibacumab from GSK

Emergent BioSolutions Inc. bought rights to GlaxoSmithKline PLC's monoclonal antibody raxibacumab in an all-cash transaction.

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Artemis alcohol-free antiseptic foam hand sanitizer [Artemis Bio-Solutions Inc]

ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Sanitizer

Artemis alcohol-free antiseptic foam hand [Artemis Bio-Solutions Inc]

ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Soap

Alprazolam [Sun Pharma Global FZE]

Alprazolam Tablets, USP CIV

Zolpidem tartrate [NorthStar Rx LLC]

These highlights do not include all the information needed to use zolpidem tartrate safely and effectively. See full prescribing information for zolpidem tartrate tablets.Zolpidem Tartrate Tablets CIV...

Zaleplon [Greenstone LLC]

PubMed Articles [118 Associated PubMed Articles listed on BioPortfolio]

Mortality Following Emergent Trauma Laparotomy: a Multicenter, Retrospective Study: Mortality after Emergent Trauma Laparotomy.

Two decades ago, hypotensive trauma patients requiring emergent laparotomy had a 40% mortality. In the interim, multiple interventions to decrease hemorrhage-related mortality have been implemented bu...

Emergent cholecystectomy is superior to percutaneous cholecystostomy tube placement in critically ill patients with emergent calculous cholecystitis.

The role of percutaneous cholecystostomy (PC) is undefined in patients with multiple comorbidities presenting with emergent calculous cholecystitis (CC). This study compared outcomes between PC, lapar...

What can Parents' Self-report of Reading Difficulties Tell Us about Their Children's Emergent Literacy at School Entry?

Research has linked family risk (FR) of reading difficulties (RD) with children's difficulties in emergent literacy development. This study is the first to apply parents' self-report of RD as a proxy ...

Delta neutrophil index as a promising prognostic marker of emergent surgical intervention for acute diverticulitis in the emergency department.

Early identification of patients with acute diverticulitis who require emergent surgical intervention in the emergency department (ED) is important to the physician. Although computed tomography (CT) ...

Emergent carotid stent removal after carotid stent thrombosis. Surgical Technique.

To present the technique for emergent removal of the thrombosed stent in acute carotid stent thrombosis in patients undergoing carotid artery angioplasty-stenting (CAS) BACKGROUND: Acute carotid stent...

Clinical Trials [118 Associated Clinical Trials listed on BioPortfolio]

Multifactorial Approach to Emergent Cerclage

Though cervical insufficiency is a common cause of second trimester pregnancy loss, the placement of an emergent cerclage in these patients is thought to improve perinatal outcomes. It is ...

Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy

The investigators aim to retrospectively map the delays in the acute care of traumatic brain injury patients necessitating emergent craniotomies.

Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression

This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when d...

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

The goal of this study is to determine if a fixed dose of 4-factor prothrombin complex concentrate (4FPCC) is as effective as the current standard of care. 4FPCC is used to reverse the eff...

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

This is a randomized, active comparator-controlled, parallel-group, multi-site, double-blind safety trial of sugammadex (MK-8616) for the reversal of neuromuscular blockade (NMB) induced b...

Companies [30 Associated Companies listed on BioPortfolio]

Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodyâ€...

Emergent BioSolutions

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission—to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therape...

Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, E...

Emergent Financial Group, Inc.

Emergent Financial Group provides investment banking services for early stage growth companies in healthcare. By specializing on innovative healthcare companies, Emergent has deve...

Pantec Biosolutions AG

Pantec Biosolutions specializes in precise skin microporation technology. Our proprietary P.L.E.A.S.E.® (Precise Laser EpidermAl SystEm) technology has been developed for:

More Information about "Emergent BioSolutions Inc." on BioPortfolio

We have published hundreds of Emergent BioSolutions Inc. news stories on BioPortfolio along with dozens of Emergent BioSolutions Inc. Clinical Trials and PubMed Articles about Emergent BioSolutions Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Emergent BioSolutions Inc. Companies in our database. You can also find out about relevant Emergent BioSolutions Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record